149 related articles for article (PubMed ID: 34911608)
1. Magnetic resonance spectroscopy features of the thalamus and the cerebellum and their association with clinical features in children with autism spectrum disorder: a prospective study.
Kang QQ; Li X; Tong GL; Fan YL; Shi L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec; 23(12):1250-1255. PubMed ID: 34911608
[TBL] [Abstract][Full Text] [Related]
2. [Proton magnetic resonance spectroscopy in children with atypical autism comorbid with psychomotor disinhibition syndrome].
Grechanyi SV; Suf El-Zhil LR; Ivanov DO; Pozdnyakova OF; Sergeev AM; Atamanova EE; Pozdnyakov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11. Vyp. 2):12-18. PubMed ID: 35038841
[TBL] [Abstract][Full Text] [Related]
3. A Proton Magnetic Resonance Spectroscopic Study in Autism Spectrum Disorder Using a 3-Tesla Clinical Magnetic Resonance Imaging (MRI) System: The Anterior Cingulate Cortex and the Left Cerebellum.
Ito H; Mori K; Harada M; Hisaoka S; Toda Y; Mori T; Goji A; Abe Y; Miyazaki M; Kagami S
J Child Neurol; 2017 Jul; 32(8):731-739. PubMed ID: 28420309
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.
Libero LE; Reid MA; White DM; Salibi N; Lahti AC; Kana RK
Autism Res; 2016 Jun; 9(6):643-57. PubMed ID: 26526126
[TBL] [Abstract][Full Text] [Related]
5. Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501).
Du Y; Chen L; Yan MC; Wang YL; Zhong XL; Xv CX; Li YB; Cheng Y
Mol Psychiatry; 2023 Jul; 28(7):3092-3103. PubMed ID: 37117459
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
7. A proton MR spectroscopy study of the thalamus in twins with autism spectrum disorder.
Hegarty JP; Gu M; Spielman DM; Cleveland SC; Hallmayer JF; Lazzeroni LC; Raman MM; Frazier TW; Phillips JM; Reiss AL; Hardan AY
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():153-160. PubMed ID: 28941767
[TBL] [Abstract][Full Text] [Related]
8. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study.
Brown MS; Singel D; Hepburn S; Rojas DC
Autism Res; 2013 Feb; 6(1):1-10. PubMed ID: 23166003
[TBL] [Abstract][Full Text] [Related]
9. Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.
Barbagallo G; Arabia G; Novellino F; Nisticò R; Salsone M; Morelli M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
Parkinsonism Relat Disord; 2018 Feb; 47():57-63. PubMed ID: 29203059
[TBL] [Abstract][Full Text] [Related]
10. Frontal lobe metabolic alterations in autism spectrum disorder: a
Margari L; De Giacomo A; Craig F; Palumbi R; Peschechera A; Margari M; Picardi F; Caldarola M; Maghenzani MA; Dicuonzo F
Neuropsychiatr Dis Treat; 2018; 14():1871-1876. PubMed ID: 30050301
[TBL] [Abstract][Full Text] [Related]
11. Atypical developmental patterns of brain chemistry in children with autism spectrum disorder.
Corrigan NM; Shaw DW; Estes AM; Richards TL; Munson J; Friedman SD; Dawson G; Artru AA; Dager SR
JAMA Psychiatry; 2013 Sep; 70(9):964-74. PubMed ID: 23903694
[TBL] [Abstract][Full Text] [Related]
12. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder.
Nair N; Hegarty JP; Cirstea CM; Gu M; Appling CB; Beversdorf DQ
Front Psychiatry; 2022; 13():898006. PubMed ID: 35935413
[TBL] [Abstract][Full Text] [Related]
14. Metabolite alterations in autistic children: a 1H MR spectroscopy study.
Kubas B; Kułak W; Sobaniec W; Tarasow E; Lebkowska U; Walecki J
Adv Med Sci; 2012 Jun; 57(1):152-6. PubMed ID: 22472469
[TBL] [Abstract][Full Text] [Related]
15. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
[TBL] [Abstract][Full Text] [Related]
16. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
[TBL] [Abstract][Full Text] [Related]
17. Correlations between facial emotion processing and biochemical abnormalities in untreated adolescent patients with major depressive disorder: A proton magnetic resonance spectroscopy study.
Lv S; Zhong S; Zhang S; Lai S; Wang Y; Zhao H; Zhang Y; Luo Y; Yan S; Ran H; Chen P; Chen G; Jia Y
J Affect Disord; 2022 Jan; 296():408-417. PubMed ID: 34638025
[TBL] [Abstract][Full Text] [Related]
18. Exploring Changes in Thalamus Metabolites as Diagnostic Biomarkers in Idiopathic Generalised Epilepsy Patients Using Magnetic Resonance Spectroscopy.
Abedi-Firouzjah R; Rostamzadeh A; Banaei A; Shafiee M; Moghaddam ZM; Vafapour H
Malays J Med Sci; 2020 Feb; 27(1):78-86. PubMed ID: 32158347
[TBL] [Abstract][Full Text] [Related]
19. Thalamic metabolic alterations with cognitive dysfunction in idiopathic trigeminal neuralgia: a multivoxel spectroscopy study.
Wang Y; Li D; Bao F; Ma S; Guo C; Jin C; Zhang M
Neuroradiology; 2014 Aug; 56(8):685-93. PubMed ID: 24820951
[TBL] [Abstract][Full Text] [Related]
20. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
